Skip to Main content Skip to Navigation
Journal articles

French law: what about a reasoned reimbursement of serum vitamin D assays?

Jc Souberbielle 1 France Benhamou 2 Bernard Cortet 3 France Rousière France Roux 4 France Abitbol France Annweiler France Audran 5 France Bacchetta Philippe Bataille 6 Olivier Beauchet 7 R Bardet Alexandra Benachi 8 France Berenbaum 9, 10 Hubert Blain 11 France Borson-Chazot 12 Véronique Breuil 13 Philippe Brunet 14 Philippe Caron 15 France Chabre Philippe Chanson 16 France Chapurlat France Cochat R Coutant Karine Briot 17 France Christin-Maitre Martin Cohen-Solal 18, 19 France Combe 20 France Cormier 21 Georges Courbebaisse France Debrus France Delemer Georges Deschenes 22 Marc Duquenne France Duval 23 France Fardellone France Fouque 24 Georges Friedlander 25 Bernard Jean 26 France Groussin Pascal Guggenbuhl 27 Georges Houillier Thierry Hannedouche William Jacot 28 France Javier France Jeandel Dominique Joly France Kamenicky France Knebelmann France Lafage-Proust Yves Lebouc Erick Legrand Florence Levy-Weil France Linglart France Machet France Maheu Eric Mallet 29 France Marcelli France Marès France Mariat Georges Maruani Yves Maugars 30 France Montagnon Bruno Moulin 31 Philippe Orcel 32 Henri Partouche 33 Virginie Personne 34 Charles Pierrot-Deseilligny 35 Michel Polak 36 Claire Pouteil-Noble 37 Dominique Prié 38 Agathe Raynaud-Simon Yves Rolland Jean-Louis Sadoul 39 Bernard Salle Corinne Sault Anne-Marie Schott Isabelle Sermet-Gaudelus 40 Martin Soubrier 41 Ivan Tack 42 Georges Thervet Isabelle Tostivint Philippe Touraine 43, 44 Florence Tremollières 45 Pablo Urena-Torres Jean-Paul Viard 46, 47 Jean-Louis Wemeau Georges Weryha 48 Norbert Winer 49 Jacques Young Thierry Thomas 50 
15 Trigone-CIREL
CIREL - Centre Interuniversitaire de Recherche en Education de Lille - ULR 4354 : EA1038
Abstract : The number of serum 25-hydroxyvitamin D (25OHD) assays has increased tenfold in France in less than 10 years, sometimes for invalidated reasons. In 2013, the French National Authority for Health (Haute autorité de santé, or HAS) limited the indications for serum 25OHD measurements to rickets/osteomalacia, older adults with recurrent falls, monitoring of kidney transplant in adults, and surgical treatment of obesity in adults. Our aim here was to note that other indications for serum 25OHD measurements are supported by previous literature and by a number of national and international recommendations, in particular the following: any situation of bone fragility, any chronic renal failure <45 mL/min/1.73m(2), any situation of malabsorption, clinical signs consistent with vitamin D deficiency or vitamin D overload, and calcium phosphorus evaluation. We suggest that the measurement of serum 25OHD concentration should remain reimbursed as part of these extended indications.
Document type :
Journal articles
Complete list of metadata
Contributor : Françoise DIGNAT-GEORGE Connect in order to contact the contributor
Submitted on : Monday, February 13, 2017 - 11:41:03 AM
Last modification on : Friday, August 12, 2022 - 2:01:22 PM



Jc Souberbielle, France Benhamou, Bernard Cortet, France Rousière, France Roux, et al.. French law: what about a reasoned reimbursement of serum vitamin D assays?. Gériatrie et psychologie & neuropsychiatrie du vieillissement, John Libbey Eurotext, 2016, 14 (4), pp.377-382. ⟨10.1684/pnv.2016.0631⟩. ⟨hal-01465951⟩



Record views